zł840.00
0.00% yesterday
Warsaw, Oct 13, 03:22 pm CET
ISIN
SI0031102120
Symbol
KRK

Krka Stock price

zł828.00
-100.00 10.78% 1M
+104.00 14.36% 6M
+242.00 41.30% YTD
+242.00 41.30% 1Y
+391.00 89.47% 3Y
+460.00 125.00% 5Y
+578.00 231.20% 10Y
+618.00 294.29% 20Y
Warsaw, Closing price Mon, Oct 13 2025
-12.00 1.43%
ISIN
SI0031102120
Symbol
KRK
Sector

Key metrics

Basic
Market capitalization
zł36.9b
Enterprise Value
zł61.0b
Net debt
zł24.2b
Cash
zł69.4b
Shares outstanding
2.5b
Valuation (TTM | estimate)
P/E
4,140.0 | 808.5
P/S
0.2 | 0.2
EV/Sales
0.3 | 0.3
EV/FCF
negative
P/B
0.7
Dividends
DPS
zł32.09
Yield 1Y | 5Y
3.9% | 4.8%
Growth 1Y | 5Y
100.0% | -
Payout 1Y | 3Y
0.0% | 1,249.8%
Increased
1 Year
Financials (TTM | estimate)
Revenue
zł208.0b | zł205.4b
EBITDA
zł12.2b | zł13.9b
EBIT
zł6.2b | zł10.2b
Net Income
zł514.7m | zł2.6b
Free Cash Flow
zł-24.2b
Growth (TTM | estimate)
Revenue
-12.6% | 0.7%
EBITDA
-46.3% | 76.0%
EBIT
-66.8% | 78.2%
Net Income
-84.7% | 2,158.3%
Free Cash Flow
-347.7%
Margin (TTM | estimate)
Gross
15.1%
EBITDA
5.9% | 6.8%
EBIT
3.0%
Net
0.3% | 1.3%
Free Cash Flow
-11.6%
Financial Health
Equity Ratio
13.5%
Return on Equity
0.3%
ROCE
4.6%
ROIC
0.9%
Debt/Equity
1.8
More
EPS
zł0.2
FCF per Share
zł-9.5
Short interest
-
Employees
131k
Rev per Employee
zł1.6m
Show more

Is Krka a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,002 stocks worldwide.

Krka Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Krka forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Krka forecast:

Buy
92%
Hold
8%

Financial data from Krka

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
208,014 208,014
13% 13%
100%
- Direct Costs 176,669 176,669
9% 9%
85%
31,345 31,345
29% 29%
15%
- Selling and Administrative Expenses 25,505 25,505
3% 3%
12%
- Research and Development Expense 710 710
23% 23%
0%
12,224 12,224
46% 46%
6%
- Depreciation and Amortization 6,059 6,059
44% 44%
3%
EBIT (Operating Income) EBIT 6,165 6,165
67% 67%
3%
Net Profit 515 515
85% 85%
0%

In millions PLN.

Don't miss a Thing! We will send you all news about Krka directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

KRKA dd is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of human and animal health products. It operates through the following geographical segments: European Union, South-East Europe, Eastern Europe, and Other. The European Union segment includes all countries of the European Union. The South-East Europe segment consists of Serbia, Bosnia and Herzegovina, Macedonia, Montenegro, Kosovo, and Albania. The Eastern Europe segment comprises of the Russian Federation and other former Soviet Union countries, excluding the Baltic countries. The company was founded by Boris Andrijanic in 1954 and is headquartered in Novo Mesto, Slovenia.

Head office Slovenia
CEO Jože Colaric
Employees 130,760
Founded 1954
Website www.koc.com.tr

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today